Will plasma exchange (plex) remove steroids and should steroids be administered post-procedure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Plasma Exchange and Steroid Administration

Plasma exchange does not meaningfully remove steroids, and steroids should be administered concurrently with plasma exchange, not after the procedure. 1, 2

Steroid Removal During Plasma Exchange

  • Steroids are not significantly removed by plasma exchange because corticosteroids like methylprednisolone and prednisone have high protein binding and tissue distribution, making them relatively resistant to removal during the procedure 1
  • The primary concern with plasma exchange is removal of large molecules like immunoglobulins, rituximab, and IVIG—not small molecule drugs like corticosteroids 2
  • This is fundamentally different from biologics: rituximab must be given 48-72 hours after plasma exchange because the procedure removes the drug, but this timing concern does not apply to steroids 1, 2

Timing of Steroid Administration with Plasma Exchange

Steroids should be given concurrently with plasma exchange, not sequentially after:

  • High-dose pulse corticosteroids (methylprednisolone 1g daily for 3-5 days) should be administered in conjunction with plasma exchange for severe autoimmune conditions, particularly ANCA-associated vasculitis with severe renal involvement or diffuse alveolar hemorrhage 1, 3
  • The standard approach is to continue or initiate corticosteroids while performing plasma exchange sessions over 7-14 days 1
  • In ANCA vasculitis specifically, the KDIGO 2023 guidelines support plasma exchange for patients with serum creatinine >500 μmol/L requiring dialysis, with concurrent glucocorticoid therapy 1

Clinical Protocol

For severe autoimmune conditions requiring plasma exchange:

  • Initiate or continue oral prednisolone 0.5-1 mg/kg/day (maximum 60-80 mg/day) or pulse IV methylprednisolone 500-1000 mg daily for 3-5 days 1
  • Perform 5-7 plasma exchange sessions over 10-14 days 1, 2
  • Do not delay steroid administration waiting for plasma exchange to complete—both therapies work synergistically 3
  • After plasma exchange completion, continue oral steroid taper according to disease-specific protocols 1

Critical Timing Considerations for Other Medications

While steroids can be given concurrently, other medications require specific timing:

  • IVIG must be given AFTER plasma exchange is complete, never before, as plasma exchange will remove the immunoglobulin 3, 2, 4
  • Rituximab should be administered 48-72 hours after the last plasma exchange session to avoid removal of the drug 1, 2
  • Cyclophosphamide infusions should be given immediately after individual plasma exchange sessions 1

Common Pitfalls

  • Do not withhold steroids during plasma exchange thinking they will be removed—this delays necessary immunosuppression 1, 3
  • Do not give IVIG before or during plasma exchange—this wastes expensive therapy as it will be removed 3, 2
  • Plasma exchange can remove clotting factors and cause coagulation defects, requiring monitoring, but this does not affect steroid pharmacokinetics 2
  • The combination of plasma exchange with immunosuppressants increases infection risk, requiring prophylactic measures for opportunistic infections 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Plasmapheresis Indications and Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pulsoterapia em Condições Autoimunes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IVIG Therapy for Autoimmune Small Fiber Neuropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.